Comparison 2. Different types of antifungals.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cured (terbinafine 250 mg/day versus itraconazole 100 mg/day)	4		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 week 4	1	44	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.61, 1.43]
1.2 week 8	2	166	Risk Ratio (M‐H, Random, 95% CI)	1.28 [0.82, 1.98]
1.3 week 12 plus	1	129	Risk Ratio (M‐H, Random, 95% CI)	1.14 [0.93, 1.41]
1.4 common treatment length (4 weeks)	3	222	Risk Ratio (M‐H, Random, 95% CI)	1.07 [0.92, 1.25]
2 Cured (itraconazole 100 mg/day versus fluconazole 50 mg/day)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 week 10	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Cured (fluconazole 50 mg/day versus ketoconazole 200 mg/day)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 week 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Cured (ketaconazole 200 mg/day versus griseofulvin 1000 mg/day)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 week 8	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Cured (terbinafine 250 mg versus griseofulvin 500 mg)	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5.1 week 4	1	43	Risk Ratio (M‐H, Fixed, 95% CI)	2.59 [1.38, 4.85]
5.2 week 8	1	28	Risk Ratio (M‐H, Fixed, 95% CI)	1.94 [1.12, 3.36]
5.3 last outcome point	2	71	Risk Ratio (M‐H, Fixed, 95% CI)	2.26 [1.49, 3.44]
6 Cured (fluconazole 150 mg/week versus fluconazole 50 mg/day)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
6.1 week 10	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Cured (terbinafine 250 mg/2 weeks versus terbinafine 250 mg/4 weeks)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected